報告摘要

The global Major Histocompatibility Complex market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the Major Histocompatibility Complex market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Major Histocompatibility Complex market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Major Histocompatibility Complex market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Major Histocompatibility Complex include Santa Cruz Biotechnology, ProImmune, Novus Biologicals, Miltenyi Biotec, Creative BioMart and Abbexa, among others; in 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Major Histocompatibility Complex market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Major Histocompatibility Complex. Key Companies & Market Share Insights This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Major Histocompatibility Complex Market by Company Santa Cruz Biotechnology ProImmune Novus Biologicals Miltenyi Biotec Creative BioMart Abbexa Major Histocompatibility Complex Segment by Type MHC Class II MHC Class III MHC Class I Major Histocompatibility Complex Segment by Application Medical Care Research Other Major Histocompatibility Complex Segment by Region North America United States Canada Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Histocompatibility Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Major Histocompatibility Complex and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Histocompatibility Complex. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Major Histocompatibility Complex companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Major Histocompatibility Complex by Type 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) 2.2.2 MHC Class II 2.2.3 MHC Class III 2.2.4 MHC Class I 2.3 Major Histocompatibility Complex by Application 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.3.2 Medical Care 2.3.3 Research 2.3.4 Other 2.4 Assumptions and Limitations 3 Major Histocompatibility Complex Breakdown Data by Type 3.1 Global Major Histocompatibility Complex Historic Market Size by Type (2021-2026) 3.2 Global Major Histocompatibility Complex Forecasted Market Size by Type (2027-2032) 4 Major Histocompatibility Complex Breakdown Data by Application 4.1 Global Major Histocompatibility Complex Historic Market Size by Application (2021-2026) 4.2 Global Major Histocompatibility Complex Forecasted Market Size by Application (2027-2032) 5 Global Growth Trends 5.1 Global Major Histocompatibility Complex Market Perspective (2021-2032) 5.2 Global Major Histocompatibility Complex Growth Trends by Region 5.2.1 Global Major Histocompatibility Complex Market Size by Region: 2021 VS 2025 VS 2032 5.2.2 Major Histocompatibility Complex Historic Market Size by Region (2021-2026) 5.2.3 Major Histocompatibility Complex Forecasted Market Size by Region (2027-2032) 5.3 Major Histocompatibility Complex Market Dynamics 5.3.1 Major Histocompatibility Complex Industry Trends 5.3.2 Major Histocompatibility Complex Market Drivers 5.3.3 Major Histocompatibility Complex Market Challenges 5.3.4 Major Histocompatibility Complex Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Major Histocompatibility Complex Players by Revenue 6.1.1 Global Top Major Histocompatibility Complex Players by Revenue (2021-2026) 6.1.2 Global Major Histocompatibility Complex Revenue Market Share by Players (2021-2026) 6.2 Global Major Histocompatibility Complex Industry Players Ranking, 2023 VS 2024 VS 2025 6.3 Global Key Players of Major Histocompatibility Complex Head Office and Area Served 6.4 Global Major Histocompatibility Complex Players, Product Type & Application 6.5 Global Major Histocompatibility Complex Manufacturers Established Date 6.6 Global Major Histocompatibility Complex Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Major Histocompatibility Complex Market Size (2021-2032) 7.2 North America Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 7.3 North America Major Histocompatibility Complex Market Size by Country (2021-2026) 7.4 North America Major Histocompatibility Complex Market Size by Country (2027-2032) 7.5 United States 7.5 United States 7.6 Canada 7.7 Mexico 8 Europe 8.1 Europe Major Histocompatibility Complex Market Size (2021-2032) 8.2 Europe Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 8.3 Europe Major Histocompatibility Complex Market Size by Country (2021-2026) 8.4 Europe Major Histocompatibility Complex Market Size by Country (2027-2032) 8.5 Germany 8.6 France 8.7 U.K. 8.8 Italy 8.9 Spain 8.10 Russia 8.11 Netherlands 8.12 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Major Histocompatibility Complex Market Size (2021-2032) 9.2 Asia-Pacific Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 9.3 Asia-Pacific Major Histocompatibility Complex Market Size by Country (2021-2026) 9.4 Asia-Pacific Major Histocompatibility Complex Market Size by Country (2027-2032) 9.5 China 9.6 Japan 9.7 South Korea 9.8 India 9.9 Australia 9.10 China Taiwan 9.11 Southeast Asia 10 South America 10.1 South America Major Histocompatibility Complex Market Size (2021-2032) 10.2 South America Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 10.3 South America Major Histocompatibility Complex Market Size by Country (2021-2026) 10.4 South America Major Histocompatibility Complex Market Size by Country (2027-2032) 10.5 Brazil 10.6 Argentina 10.7 Chile 10.8 Colombia 10.9 Peru 11 Middle East & Africa 11.1 Middle East & Africa Major Histocompatibility Complex Market Size (2021-2032) 11.2 Middle East & Africa Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 11.3 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026) 11.4 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2027-2032) 11.5 Saudi Arabia 11.6 Israel 11.7 United Arab Emirates 11.8 Turkey 11.9 Iran 11.10 Egypt 12 Players Profiled 12.1 Santa Cruz Biotechnology 12.1.1 Santa Cruz Biotechnology Company Information 12.1.2 Santa Cruz Biotechnology Business Overview 12.1.3 Santa Cruz Biotechnology Revenue in Major Histocompatibility Complex Business (2021-2026) 12.1.4 Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio 12.1.5 Santa Cruz Biotechnology Recent Developments 12.2 ProImmune 12.2.1 ProImmune Company Information 12.2.2 ProImmune Business Overview 12.2.3 ProImmune Revenue in Major Histocompatibility Complex Business (2021-2026) 12.2.4 ProImmune Major Histocompatibility Complex Product Portfolio 12.2.5 ProImmune Recent Developments 12.3 Novus Biologicals 12.3.1 Novus Biologicals Company Information 12.3.2 Novus Biologicals Business Overview 12.3.3 Novus Biologicals Revenue in Major Histocompatibility Complex Business (2021-2026) 12.3.4 Novus Biologicals Major Histocompatibility Complex Product Portfolio 12.3.5 Novus Biologicals Recent Developments 12.4 Miltenyi Biotec 12.4.1 Miltenyi Biotec Company Information 12.4.2 Miltenyi Biotec Business Overview 12.4.3 Miltenyi Biotec Revenue in Major Histocompatibility Complex Business (2021-2026) 12.4.4 Miltenyi Biotec Major Histocompatibility Complex Product Portfolio 12.4.5 Miltenyi Biotec Recent Developments 12.5 Creative BioMart 12.5.1 Creative BioMart Company Information 12.5.2 Creative BioMart Business Overview 12.5.3 Creative BioMart Revenue in Major Histocompatibility Complex Business (2021-2026) 12.5.4 Creative BioMart Major Histocompatibility Complex Product Portfolio 12.5.5 Creative BioMart Recent Developments 12.6 Abbexa 12.6.1 Abbexa Company Information 12.6.2 Abbexa Business Overview 12.6.3 Abbexa Revenue in Major Histocompatibility Complex Business (2021-2026) 12.6.4 Abbexa Major Histocompatibility Complex Product Portfolio 12.6.5 Abbexa Recent Developments 13 Report Conclusion 14 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Major Histocompatibility Complex Revenue Market Share by Type (2021-2026) Table 7. Global Major Histocompatibility Complex Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Major Histocompatibility Complex Revenue Market Share by Type (2027-2032) Table 9. Global Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Major Histocompatibility Complex Revenue Market Share by Application (2021-2026) Table 11. Global Major Histocompatibility Complex Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Major Histocompatibility Complex Revenue Market Share by Application (2027-2032) Table 13. Global Major Histocompatibility Complex Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Major Histocompatibility Complex Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Major Histocompatibility Complex Market Share by Region (2021-2026) Table 16. Global Major Histocompatibility Complex Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Major Histocompatibility Complex Market Share by Region (2027-2032) Table 18. Major Histocompatibility Complex Industry Trends Table 19. Major Histocompatibility Complex Industry Drivers Table 20. Major Histocompatibility Complex Industry Opportunities and Challenges Table 21. Major Histocompatibility Complex Market Restraints Table 22. Global Top Major Histocompatibility Complex Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Major Histocompatibility Complex Revenue Market Share by Players (2021-2026) Table 24. Global Major Histocompatibility Complex Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Major Histocompatibility Complex, Headquarters and Area Served Table 26. Global Major Histocompatibility Complex Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Major Histocompatibility Complex by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Major Histocompatibility Complex Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Major Histocompatibility Complex Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Major Histocompatibility Complex Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Major Histocompatibility Complex Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Major Histocompatibility Complex Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Major Histocompatibility Complex Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2027-2032) & (US$ Million) Table 45. Santa Cruz Biotechnology Company Information Table 46. Santa Cruz Biotechnology Business Overview Table 47. Santa Cruz Biotechnology Revenue in Major Histocompatibility Complex Business (2021-2026) & (US$ Million) Table 48. Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio Table 49. Santa Cruz Biotechnology Recent Developments Table 50. ProImmune Company Information Table 51. ProImmune Business Overview Table 52. ProImmune Revenue in Major Histocompatibility Complex Business (2021-2026) & (US$ Million) Table 53. ProImmune Major Histocompatibility Complex Product Portfolio Table 54. ProImmune Recent Developments Table 55. Novus Biologicals Company Information Table 56. Novus Biologicals Business Overview Table 57. Novus Biologicals Revenue in Major Histocompatibility Complex Business (2021-2026) & (US$ Million) Table 58. Novus Biologicals Major Histocompatibility Complex Product Portfolio Table 59. Novus Biologicals Recent Developments Table 60. Miltenyi Biotec Company Information Table 61. Miltenyi Biotec Business Overview Table 62. Miltenyi Biotec Revenue in Major Histocompatibility Complex Business (2021-2026) & (US$ Million) Table 63. Miltenyi Biotec Major Histocompatibility Complex Product Portfolio Table 64. Miltenyi Biotec Recent Developments Table 65. Creative BioMart Company Information Table 66. Creative BioMart Business Overview Table 67. Creative BioMart Revenue in Major Histocompatibility Complex Business (2021-2026) & (US$ Million) Table 68. Creative BioMart Major Histocompatibility Complex Product Portfolio Table 69. Creative BioMart Recent Developments Table 70. Abbexa Company Information Table 71. Abbexa Business Overview Table 72. Abbexa Revenue in Major Histocompatibility Complex Business (2021-2026) & (US$ Million) Table 73. Abbexa Major Histocompatibility Complex Product Portfolio Table 74. Abbexa Recent Developments Table 75. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Major Histocompatibility Complex Product Image Figure 5. Global Major Histocompatibility Complex Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Major Histocompatibility Complex Market Share by Type: 2025 VS 2032 Figure 7. MHC Class II Product Figure 8. MHC Class III Product Figure 9. MHC Class I Product Figure 10. Global Major Histocompatibility Complex Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Major Histocompatibility Complex Market Share by Application: 2025 VS 2032 Figure 12. Medical Care Product Figure 13. Research Product Figure 14. Other Product Figure 15. Global Major Histocompatibility Complex Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Major Histocompatibility Complex Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Major Histocompatibility Complex Market Share by Region: 2025 VS 2032 Figure 18. Global Major Histocompatibility Complex Market Share by Players in 2025 Figure 19. Global Major Histocompatibility Complex Manufacturers Established Date Figure 20. Global Top 5 and 10 Major Histocompatibility Complex Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 24. United States Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 27. Europe Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 29. Germany Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 39. China Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 44. Australia Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 49. Brazil Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Major Histocompatibility Complex Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Santa Cruz Biotechnology Revenue Growth Rate in Major Histocompatibility Complex Business (2021-2026) Figure 55. ProImmune Revenue Growth Rate in Major Histocompatibility Complex Business (2021-2026) Figure 56. Novus Biologicals Revenue Growth Rate in Major Histocompatibility Complex Business (2021-2026) Figure 57. Miltenyi Biotec Revenue Growth Rate in Major Histocompatibility Complex Business (2021-2026) Figure 58. Creative BioMart Revenue Growth Rate in Major Histocompatibility Complex Business (2021-2026) Figure 59. Abbexa Revenue Growth Rate in Major Histocompatibility Complex Business (2021-2026)

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Major Histocompatibility Complex Industry Research Report 2026

授權報價

報告摘要

提及公司